Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ErbB2 genetic cancer vaccine in nonhuman primates: relevance of single nucleotide polymorphisms.

Human gene therapy - 1 Mar 2009

Fattori Elena, Aurisicchio Luigi, Zampaglione Immacolata, Arcuri Mirko, Cappelletti Manuela, Cipriani Barbara, Mennuni Carmela, Calvaruso Francesco, Nuzzo Maurizio, Ciliberto Gennaro, Monaci Paolo, La Monica Nicola

Abstract excerpt

Aberrant Her2/neu expression is associated with the development of epithelial-derived human carcinomas and for this reason it is considered a good target for immunologic intervention. To define methods to circumvent immunologic tolerance and to elicit immunity against the Her2/neu tumor-associate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, erbB-2
Share to Immunity, Cellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunization, Secondary

Share to Macaca mulatta

Share to Neoplasms, Glandular and Epithelial

Share to Recombinant Proteins

Share to Self Tolerance

Share to Vaccines, DNA

Source

Identifiers

PMID: 19257854
DOI: 10.1089/hum.2008.153

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19257854-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ErbB2 genetic cancer vaccine in nonhuman primates: relevance of single nucleotide polymorphisms.PMID 19257854Read ↗

Combining Human and Rat Sequences in Her-2 DNA Vaccines Blunts Immune Tolerance and Drives Antitumor ImmunitySemantic proximity Read ↗

Genetic immunization against neu/erbB2 transgenic breast cancer.Semantic proximity Read ↗

Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational StudySemantic proximity Read ↗

Identification and Characterization of the Immunodominant Rat HER-2/neu MHC Class I Epitope Presented by Spontaneous Mammary Tumors from HER-2/neu-Transgenic MiceSemantic proximity Read ↗

Protection against mammary tumor growth by vaccination with full-length, modified humanErbB-2 DNASemantic proximity Read ↗

Immunization of cancer patients with HER-2/neu-derived peptides demonstrating high-affinity binding to multiple class II alleles.Semantic proximity Read ↗

Human ErbB-2 (Her-2) Transgenic Mice: A Model System for Testing Her-2 Based VaccinesSemantic proximity Read ↗

A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric ProteinsSemantic proximity Read ↗

Immunobiology of Her-2/Neu Transgenic MiceSemantic proximity Read ↗

Therapeutic HER2/Neu DNA Vaccine Inhibits Mouse Tumor Naturally Overexpressing Endogenous NeuSemantic proximity Read ↗

DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.Semantic proximity Read ↗

A single low dose of dendritic cells modified with lentivirus containing a truncated neu gene can effectively suppress neu-overexpressing tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.